Source: Eur Respir J, 52 (3) 1801269; 10.1183/13993003.01269-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Rita Boaventura, Oriol Sibila, Alvar Agusti, James D. Chalmers. Treatable traits in bronchiectasis. Eur Respir J, 52 (3) 1801269; 10.1183/13993003.01269-2018

Member's Comments

No comment yet.

Related content which might interest you: Impact of comorbidities and etiology of bronchiectasis on outcomes in hospitalised patients with bronchiectasis Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Identifying undiagnosed cystic fibrosis in adults with bronchiectasis Source: Eur Respir Monogr 2018; 81: 29-44 Year: 2018 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Defining severe bronchiectasis Source: Eur Respir Monogr 2018; 81: 62-81 Year: 2018 Treatable traits: toward precision medicine of chronic airway diseases Source: Eur Respir J 2016; 47: 410-419 Year: 2016 Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 The bronchiectasis ‘bacteriophagome’ Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021 Immunodeficits in bronchiectasis Source: International Congress 2017 – PG3 Bronchiectasis Year: 2017 Bronchiectasis Source: Respipedia Article Year: 2017 Identification of asthma phenotypes based on extrapulmonary treatable traits Source: Virtual Congress 2020 – Physical activity and chronic lung disease: once a new kid, now growing up Year: 2020 Smoking in posttuberculosis bronchiectasis syndrome patients Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 How can treatable traits be used in severe exacerbations? Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC Year: 2021 Idiopathic and post-infective bronchiectasis show no clinically important differences in outcomes or airway inflammatory profiles Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Clinical and temporal characteristics of chronic bronchitis complicated with secondary bronchiectasis Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Multiple faces of non-cystic fibrosis bronchiectasis: defining etiology and disease severity Source: International Congress 2017 – Management of asthma in different situations Year: 2017 Noncystic fibrosis bronchiectasis in childhood Source: Eur Respir J 2001; 18: Suppl. 33, 171s Year: 2001 Is bronchiectasis really a disease? Source: Eur Respir Rev, 29 (155) 190051; 10.1183/16000617.0051-2019 Year: 2020